Hosted on MSN
Biocurious: IPO candidate Nexsen Biotech tackles global infant killer with early diagnosis tool
Nexsen Biotech has developed a simple-point-of care test to detect group B streptococcus in pregnant women The tool also has applications in bovine mastitis and, potentially, prostate cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results